SCHEMBL24017089

SCHEMBL24017089

CCCCCCCCN1C(=O)c2cnc3c4ncc5c6c(cnc(c7ncc(c2c37)C1=O)c64)C(=O)N(CCCCCCCC)C5=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 3/20 0.47
▸ PTGS2 P35354 3/20 0.47
▸ MGLL Q99685 3/20 0.47
▸ FAAH O00519 1/20 0.47
▸ CDC25A P30304 9/20 0.44
▸ CES1 P23141 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ RGS12 O14924 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALDH2 P05091 1/20 0.42
▸ ALDH3A1 P30838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20964344 0.97 PTGS1 (0.45) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL20964322 0.87 STAT3 (0.47) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL24017084 0.87 MGLL (0.41) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL20964336 0.85 PDE5A (0.38) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL24603645 0.83 MGLL (0.43) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL24604090 0.82 PTGS1 (0.35) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL22605887 0.82 MEN1 (0.51) CDC25ACES1ALDH1A1KDM4EMEN1
SCHEMBL7484669 0.81 ALDH1A1 (0.65) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL12132257 0.81 ALDH1A1 (0.65) PTGS1PTGS2MGLLFAAHCDC25A
SCHEMBL13176359 0.81 ALDH1A1 (0.65) PTGS1PTGS2MGLLFAAHCDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025901-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND FUJIFILM CORPORATION (JP) 2024-01-25 — — US disclosed
US-20240025901-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND FUJIFILM CORPORATION (JP) 2024-01-25 — — US disclosed
US-11785845-B2 Composition FUJIFILM CORPORATION (JP) 2023-10-10 — — US disclosed
US-11785845-B2 Composition FUJIFILM CORPORATION (JP) 2023-10-10 — — US disclosed
US-20220213104-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND FUJIFILM CORPORATION (JP) 2022-07-07 — — US disclosed
US-20220045283-A1 COMPOSITION FUJIFILM CORPORATION (JP) 2022-02-10 — — US disclosed
US-20210351363-A1 ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, COMPOUND, ORGANIC THIN FILM TRANSISTOR-FORMING COMPOSITION, AND METHOD OF MANUFACTURING ORGANIC THIN FILM TRANSISTOR FUJIFILM CORPORATION (JP) 2021-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025901-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND INF2, NISCH, ITPA PTGS1 1043/4885PTGS2 605/4885MGLL 3660/4885
US-20220045283-A1 COMPOSITION ADH1A, ADH1C, SLC19A2 PTGS1 795/4885PTGS2 1829/4885MGLL 1276/4885
US-11785845-B2 Composition ADH1A, ADH1C, SLC19A2 PTGS1 795/4885PTGS2 1829/4885MGLL 1276/4885
US-20210351363-A1 ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, COMPOUND, ORGANIC THIN FILM TRANSISTOR-FORMING COMPOSITION, AND METHOD OF MANUFACTURING ORGANIC THIN FILM TRANSISTOR OSTC, FTO, PORCN PTGS1 4083/4885PTGS2 3721/4885MGLL 1065/4885
US-20220213104-A1 METHOD FOR PRODUCING CYCLIC IMIDE COMPOUND, COMPOSITION, AND COMPOUND INF2, NISCH, ITPA PTGS1 1043/4885PTGS2 605/4885MGLL 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback